Schülke & Mayr GmbH, Department of Product Development Hygiene/Bioscience, Robert-Koch-Str. 2, 22851 Norderstedt, Germany.
Appl Environ Microbiol. 2010 Jan;76(2):546-54. doi: 10.1128/AEM.01660-09. Epub 2009 Nov 30.
To prevent transmission of mycobacterial pathogens, medical devices must be disinfected by germicides with proven mycobactericidal activity. The quantitative carrier test EN 14563 provides an international standard for evaluation of the mycobactericidal activity of disinfectants under practical conditions. However, tests according to the EN 14563 standard are based on cultivation, and results are available only after 21 days. The aim of this study was to accelerate assessment of dosage and contact times of mycobactericidal preparations based on the EN 14563 standard. To this end, a gfp gene was constructed with a codon usage adapted for Mycobacterium tuberculosis. Expression of the gfp(m)(2+) gene in Mycobacterium terrae improved the detection sensitivity by 10-fold over that with a previously used reporter strain. Peracetic acid and a cation-active formulation were tested as commercially available disinfectants for medical devices. M. terrae expressing gfp(m)(2+) was used to determine dosage and contact times for the two test germicides. Fluorescence measurements correlated well with growth of the reporter strain, demonstrating that the fluorescence reliably indicated the number of viable cells. The fluorescence enabled us to determine the mycobactericidal efficacy of the test disinfectants according to the quantitative carrier test EN 14563 standard within at least 15 days. In conclusion, this study establishes gfp(m)(2+)-expressing M. terrae as a new reporter strain for reliable evaluation of mycobactericidal activities of disinfectants with a superior sensitivity and in a significantly shorter time than previously possible.
为了防止分枝杆菌病原体的传播,医疗器械必须使用具有已证明的分枝杆菌杀菌活性的杀菌剂进行消毒。定量载体试验 EN 14563 为评估消毒剂在实际条件下的分枝杆菌杀菌活性提供了国际标准。然而,根据 EN 14563 标准进行的测试基于培养,并且只有在 21 天后才能获得结果。本研究的目的是根据 EN 14563 标准加速评估分枝杆菌杀菌制剂的剂量和接触时间。为此,构建了一个具有适应结核分枝杆菌密码子用法的 GFP 基因。在 Mycobacterium terrae 中表达 GFP(m)(2+)基因使检测灵敏度比以前使用的报告菌株提高了 10 倍。过氧乙酸和阳离子活性制剂被测试为用于医疗器械的市售消毒剂。使用表达 GFP(m)(2+)的 M. terrae 来确定两种测试杀菌剂的剂量和接触时间。荧光测量与报告菌株的生长非常吻合,证明荧光可靠地指示了活细胞的数量。荧光使我们能够根据定量载体试验 EN 14563 标准在至少 15 天内确定测试消毒剂的杀菌效果。总之,本研究建立了表达 GFP(m)(2+)的 M. terrae 作为一种新的报告菌株,用于可靠评估消毒剂的分枝杆菌杀菌活性,其灵敏度优于以前,且所需时间明显缩短。